Raise3D Secures Tens of Millions in Pre-B Financing to Advance Dental 3D Printing Innovations

On September 25, 2025, Panda3dp.com reported that Suzhou Raise3D Intelligent Technology Co., Ltd.—a provider of integrated dental 3D printing solutions—successfully completed a Pre-B funding round worth tens of millions of RMB. The round was co-led by Falcon Investment’s Xingqi Fund and Xieli Investment, with Dongzheng Capital joining as a follow-up investor, and Index Capital serving as exclusive financial advisor. The funds will primarily support R&D and overseas market expansion.

Founded in 2019, Raise3D focuses on comprehensive dental 3D printing and integrated digital workflow solutions. Its R&D covers optics, electronics, mechanics, software, algorithms, and materials—including AI-driven design and proprietary resin development. The company delivers full-stack solutions encompassing hardware, software, materials, and technical services. To date, its client base spans leading Chinese dental labs, major public hospitals, large dental chains, key distributors, and top global brands. Raise3D has also partnered with more than 100 overseas companies across Europe, North Africa, Asia-Pacific, North America, and Latin America.

01 | Expanding Product Portfolio and Deepening Clinical Applications

Raise3D offers a complete range of products, including flagship printers like Shape1+ Dental, Edge E2, and Edge Max. In March 2025, it launched the Edge mini—a compact, dual-platform 3D printer tailored for chairside use in dental clinics. Designed for precision and efficiency, it supports a wide range of dental applications, from crowns, bridges, and veneers to surgical guides, splints, bases, and temporary restorations. The Edge mini completes a crown in just 15 minutes and a temporary denture in 20 minutes. With its intuitive “plug-and-print” interface, it greatly reduces the learning curve while enhancing clinical productivity.

With the release of the Edge mini, Raise3D is extending its reach from factory-based production to in-clinic fabrication—marking a shift from outsourced processing to on-site clinical integration. This evolution not only brings production closer to the point of care but also underscores the transition of dental 3D printing from back-end manufacturing to the core of clinical workflows. As a result, clinics gain greater autonomy and flexibility, while Raise3D positions itself as both a technology provider and an ecosystem enabler bridging lab and clinic.

Complementing its hardware portfolio, Raise3D has independently developed more than 20 high-performance photosensitive resin materials and end-use dental products. These materials feature high reliability, accuracy, and cost-efficiency, quickly establishing the company as a strong player in the global dental 3D printing market. With the maturation of chairside applications, Raise3D plans to continue advancing digital dentistry through its integrated “3D Printing + AI Software” strategy, expanding value from product to materials, and from software to full-service ecosystems.

02 | Rapid Overseas Expansion: Partnerships in Over 70 Countries

From its inception, Raise3D has prioritized global outreach, leveraging high-frequency branding and digital marketing to build an extensive international client network. As of 2025, its overseas footprint spans 70+ countries, with strategic partnerships established with renowned dental brands such as Kulzer, Detax, Bego, and DMG. Raise3D’s products have been validated for demanding clinical applications—including permanent crowns, removable dentures, and surgical implant guides—offering reliable performance to dental clinics and labs worldwide. Overseas sales are projected to grow 120% year-over-year in 2025.

The company has also completed bi-directional compatibility certifications with leading material and equipment providers such as Keystone, Saremco, Dreve, and Dentona, confirming that Raise3D’s precision, stability, and open-system design meet the stringent standards of European and North American clinical markets. These collaborations pave the way for joint marketing, cross-brand product bundles, and expanded global distribution—further strengthening Raise3D’s international presence.

03 | New Lean Manufacturing Center Enhances Capacity

In July 2025, Raise3D inaugurated its Lean Manufacturing Center in Changshu Economic Development Zone. With an investment of RMB 50 million and a facility exceeding 10,000 m², the center integrates R&D and production for dental materials and 3D printers. Once fully operational, it will deliver an annual capacity of 500 tons of dental resin materials and 10,000 printers, supporting Raise3D’s target of RMB 500 million in sales within three years.

The new center marks a milestone in Raise3D’s deepening commitment to dental digitalization and 3D printing innovation, significantly boosting production efficiency and product quality while delivering greater value to both clinics and laboratories.

04 | Investor Confidence in Continued Growth

According to Falcon Investment’s Xingqi Fund, the application of 3D printing is fundamentally reshaping the dental industry’s production models and clinical workflows—driven by global digital transformation. 3D printing is rapidly evolving from a tool for auxiliary manufacturing to a core solution in direct clinical treatment, unlocking vast market potential. They expressed confidence in Raise3D’s dedicated focus and global strategy, positioning it as a frontrunner in the dental 3D printing segment.

Xieli Investment highlighted dentistry as one of the most promising verticals for 3D printing, integral to the digitalization of oral healthcare. By integrating intraoral scanning, CAD design, and 3D printing, clinics and labs are accelerating toward smarter, more efficient operations. Xieli praised Raise3D’s strong product performance and operational excellence, emphasizing its potential to become an industry leader exemplifying “Made in China” innovation in digital dentistry.

Index Capital’s Executive Director, Chen Ge, noted that dentistry sits at the forefront of digital healthcare transformation. With 3D printing as its most commercially viable hardware platform, the technology is reshaping production relationships and enabling a new paradigm of personalized, intelligent manufacturing in oral healthcare. Under the leadership of CEO Liu, Raise3D has demonstrated clear strategic vision and exceptional execution—extending applications from fabrication to chairside treatment while building a global collaboration network. Chen concluded that Raise3D is set to redefine China’s dental 3D printing standards and emerge as a global leader in digital dentistry transformation.